These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21273763)

  • 1. A survey conducted on patients' and urologists' perceptions of benign prostatic hyperplasia.
    Kim SI; Kang JY; Lee HW; Seong do H; Cho JS
    Urol Int; 2011; 86(3):278-83. PubMed ID: 21273763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
    Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
    J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical questionnaires about benign prostatic hyperplasia].
    Zhang XH; Li X; Ye ZQ; Sun ZY; Sun YH; Sun G; Wang JY; Na YQ
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1153-5. PubMed ID: 19094678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: a Korean nationwide health insurance database study.
    Park J; Lee YJ; Lee JW; Yoo TK; Chung JI; Yun SJ; Hong JH; Seo SI; Cho SY; Son H
    Korean J Urol; 2015 Mar; 56(3):233-9. PubMed ID: 25763128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
    Seftel A; Rosen R; Kuritzky L
    Int J Impot Res; 2007; 19(4):386-92. PubMed ID: 17377613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey on the Italian outpatient urologists regarding the management of benign prostatic hyperplasia.
    Magri V; Parazzini F; Chiaffarino F
    Arch Ital Urol Androl; 2006 Mar; 78(1):11-4. PubMed ID: 16752881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benign prostatic hyperplasia; recommendations for transmural care. Working Group, Dutch College of General Practitioners and Netherlands College of Urologists].
    Klomp ML; Rosmalen CF; Romeijnders AC; Oosterhof GO; Schlatmann TJ
    Ned Tijdschr Geneeskd; 1998 Nov; 142(47):2563-8. PubMed ID: 10028352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information from your family doctor. Benign prostatic hyperplasia: what you should know.
    American Academy of Family Physicians
    Am Fam Physician; 2008 May; 77(10):1413. PubMed ID: 18533374
    [No Abstract]   [Full Text] [Related]  

  • 9. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
    Fawzy A; Fontenot C; Guthrie R; Baudier MM
    Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.
    Paick JS; Kim SW; Ku JH
    Yonsei Med J; 2007 Apr; 48(2):281-8. PubMed ID: 17461528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questionnaire survey of urologists' initial treatment practices for acute urinary retention secondary to benign prostatic hyperplasia in Korea.
    Ku JH; Kim SW; Paick JS
    Urol Int; 2006; 76(4):314-20. PubMed ID: 16679832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Perceptions of benign prostatic hyperplasia according to the perspective of patients and general practitioners - the Trophée study].
    Lacoin F; Fourcade RO; Rouprêt M; Slama A; Le Fur C; Michel E; Sitbon A; Cotté FE
    Prog Urol; 2013 Jan; 23(1):50-7. PubMed ID: 23287484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of medical treatment for benign prostatic hyperplasia (BPH).
    Roehrborn CG
    Prog Clin Biol Res; 1994; 386():175-90. PubMed ID: 7528385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urology in 2011].
    Jichlinski P
    Rev Med Suisse; 2012 Jan; 8(323):61-3. PubMed ID: 22303743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States.
    Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR
    J Urol; 1995 Jul; 154(1):205-6. PubMed ID: 7539861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?
    Stoevelaar HJ; Van de Beek C; Casparie AF; McDonnell J; Nijs HG
    J Urol; 1999 Jan; 161(1):133-8. PubMed ID: 10037385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
    Kranjcević K; Marković BB
    Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians.
    Collins MM; Barry MJ; Bin L; Roberts RG; Oesterling JE; Fowler FJ
    J Gen Intern Med; 1997 Apr; 12(4):224-9. PubMed ID: 9127226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia: current clinical practice.
    Djavan B; Eckersberger E; Finkelstein J; Espinosa G; Sadri H; Brandner R; Shah O; Lepor H
    Prim Care; 2010 Sep; 37(3):583-97, ix. PubMed ID: 20705200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction.
    Emberton M
    Int J Clin Pract; 2010 Sep; 64(10):1425-35. PubMed ID: 20579137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.